AI | Goldman Sachs Analyst Sees AI Boosting Diabetes Care at Abbott, Dexcom
2026-06-16 22:13:43
Goldman Sachs medtech and healthcare IT research analyst David Roman said AI can play a “significant” role in helping patients manage diabetes, including technology used by Abbott and Dexcom to count carbohydrates and deliver the right amount of insulin. According to Bloomberg, Roman said he left Goldman Sachs’ annual medtech conference “very bullish” on innovation across the industry.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
